{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T12:32:03Z","timestamp":1791549123117,"version":"4.3.4"},"reference-count":56,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005155","name":"Azrieli Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005155","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["154321"],"award-info":[{"award-number":["154321"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000193","name":"International Development Research Centre","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000193","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013528","name":"Diabetes Canada","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013528","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007476","name":"Canadian Diabetes Association","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007476","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004191","name":"Novo Nordisk","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004191","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003977","name":"Israel Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003977","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Metabolism"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1016\/j.molmet.2020.101008","type":"journal-article","created":{"date-parts":[[2020,5,7]],"date-time":"2020-05-07T12:06:17Z","timestamp":1588853177000},"page":"101008","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"special_numbering":"C","title":["The gut hormone receptor GIPR links energy availability to the control of hematopoiesis"],"prefix":"10.1016","volume":"39","author":[{"given":"Gemma","family":"Pujadas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elodie M.","family":"Varin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurie L.","family":"Baggio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erin E.","family":"Mulvihill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.W.Annie","family":"Bang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacqueline A.","family":"Koehler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dianne","family":"Matthews","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6688-8127","authenticated-orcid":false,"given":"Daniel J.","family":"Drucker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.molmet.2020.101008_bib1","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/j.cmet.2013.04.008","article-title":"Pharmacology physiology and mechanisms of incretin hormone action","volume":"17","author":"Campbell","year":"2013","journal-title":"Cell Metabolism"},{"key":"10.1016\/j.molmet.2020.101008_bib2","first-page":"3072","article-title":"Glucagon-like peptide 1 (GLP-1)","author":"Muller","year":"2019","journal-title":"Mol Metab"},{"issue":"1","key":"10.1016\/j.molmet.2020.101008_bib3","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.cmet.2016.06.009","article-title":"The cardiovascular biology of glucagon-like peptide-1","volume":"24","author":"Drucker","year":"2016","journal-title":"Cell Metabolism"},{"issue":"9","key":"10.1016\/j.molmet.2020.101008_bib4","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1161\/CIRCULATIONAHA.117.028136","article-title":"Cardiovascular actions and clinical outcomes with glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors","volume":"136","author":"Nauck","year":"2017","journal-title":"Circulation"},{"issue":"10160","key":"10.1016\/j.molmet.2020.101008_bib5","doi-asserted-by":"crossref","first-page":"2180","DOI":"10.1016\/S0140-6736(18)32260-8","article-title":"Efficacy and safety of LY3298176, a novel dual GIP and GLP-1 receptor agonist, in patients with type 2 diabetes: a randomised, placebo-controlled and active comparator-controlled phase 2 trial","volume":"392","author":"Frias","year":"2018","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.molmet.2020.101008_bib6","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.molmed.2016.03.005","article-title":"Reappraisal of GIP pharmacology for metabolic diseases","volume":"22","author":"Finan","year":"2016","journal-title":"Trends in Molecular Medicine"},{"issue":"1","key":"10.1016\/j.molmet.2020.101008_bib7","doi-asserted-by":"crossref","DOI":"10.1210\/endrev\/bnz002","article-title":"Glucose-dependent insulinotropic polypeptide receptor therapies for the treatment of obesity, do agonists\u00a0= antagonists?","volume":"41","author":"Killion","year":"2020","journal-title":"Endocrine Reviews"},{"key":"10.1016\/j.molmet.2020.101008_bib8","first-page":"1303786","article-title":"Gut-derived GIP activates central Rap1 to impair neural leptin sensitivity during overnutrition","author":"Kaneko","year":"2019","journal-title":"Journal of Clinical Investigation"},{"issue":"5","key":"10.1016\/j.molmet.2020.101008_bib9","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/j.cmet.2019.07.013","article-title":"Glucose-dependent insulinotropic polypeptide receptor-expressing cells in the hypothalamus regulate food intake","volume":"30","author":"Adriaenssens","year":"2019","journal-title":"Cell Metabolism"},{"key":"10.1016\/j.molmet.2020.101008_bib10","article-title":"TCF1 links GIPR signaling to the control of beta cell function and survival","volume":"2284\u201390","author":"Campbell","year":"2016","journal-title":"Nature Medicine"},{"issue":"3","key":"10.1016\/j.molmet.2020.101008_bib11","doi-asserted-by":"crossref","first-page":"E224","DOI":"10.1152\/ajpendo.00347.2016","article-title":"Glucose-dependent insulinotropic polypeptide promotes lipid deposition in subcutaneous adipocytes in obese type 2 diabetes patients: a maladaptive response","volume":"312","author":"Thondam","year":"2017","journal-title":"American Journal of Physiology. Endocrinology and Metabolism"},{"issue":"7","key":"10.1016\/j.molmet.2020.101008_bib12","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1038\/nm727","article-title":"Inhibition of gastric inhibitory polypeptide signaling prevents obesity","volume":"8","author":"Miyawaki","year":"2002","journal-title":"Nature Medicine"},{"issue":"472","key":"10.1016\/j.molmet.2020.101008_bib13","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aat3392","article-title":"Anti-obesity effects of GIPR antagonists alone and in combination with GLP-1R agonists in preclinical models","volume":"10","author":"Killion","year":"2018","journal-title":"Science Translational Medicine"},{"key":"10.1016\/j.molmet.2020.101008_bib14","first-page":"3244","article-title":"Pharmacological antagonism of the incretin system protects against diet-induced obesity","author":"Svendsen","year":"2020","journal-title":"Mol Metab"},{"issue":"2","key":"10.1016\/j.molmet.2020.101008_bib15","doi-asserted-by":"crossref","first-page":"E543","DOI":"10.1152\/ajpendo.00364.2006","article-title":"Effects of glucose-dependent insulinotropic peptide on osteoclast function","volume":"292","author":"Zhong","year":"2007","journal-title":"American Journal of Physiology. Endocrinology and Metabolism"},{"issue":"3","key":"10.1016\/j.molmet.2020.101008_bib16","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1210\/endo.141.3.7366","article-title":"Osteoblast-derived cells express functional glucose-dependent insulinotropic peptide receptors","volume":"141","author":"Bollag","year":"2000","journal-title":"Endocrinology"},{"issue":"10","key":"10.1016\/j.molmet.2020.101008_bib17","doi-asserted-by":"crossref","first-page":"2649","DOI":"10.1007\/s00125-011-2241-2","article-title":"Native incretins prevent the development of atherosclerotic lesions in apolipoprotein E knockout mice","volume":"54","author":"Nagashima","year":"2011","journal-title":"Diabetologia"},{"issue":"4","key":"10.1016\/j.molmet.2020.101008_bib18","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0035683","article-title":"Glucose-dependent insulinotropic polypeptide prevents the progression of macrophage-driven atherosclerosis in diabetic apolipoprotein E-null mice","volume":"7","author":"Nogi","year":"2012","journal-title":"PloS One"},{"key":"10.1016\/j.molmet.2020.101008_bib19","first-page":"6512","article-title":"Regulation of nutrition-associated receptors in blood monocytes of normal weight and obese humans","author":"Pivovarova","year":"2015","journal-title":"Peptides"},{"issue":"8","key":"10.1016\/j.molmet.2020.101008_bib20","doi-asserted-by":"crossref","first-page":"3089","DOI":"10.4049\/jimmunol.1601441","article-title":"Glucose-dependent insulinotropic polypeptide receptor deficiency leads to impaired bone marrow hematopoiesis","volume":"198","author":"Mantelmacher","year":"2017","journal-title":"The Journal of Immunology"},{"issue":"6","key":"10.1016\/j.molmet.2020.101008_bib21","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/j.immuni.2006.04.008","article-title":"Toll-like receptors on hematopoietic progenitor cells stimulate innate immune system replenishment","volume":"24","author":"Nagai","year":"2006","journal-title":"Immunity"},{"issue":"5","key":"10.1016\/j.molmet.2020.101008_bib22","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/j.jmb.2006.09.054","article-title":"Signaling through toll-like receptor 7\/8 induces the differentiation of human bone marrow CD34+ progenitor cells along the myeloid lineage","volume":"364","author":"Sioud","year":"2006","journal-title":"Journal of Molecular Biology"},{"issue":"2","key":"10.1016\/j.molmet.2020.101008_bib23","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1084\/jem.20101643","article-title":"Dynamic variation in cycling of hematopoietic stem cells in steady state and inflammation","volume":"208","author":"Takizawa","year":"2011","journal-title":"Journal of Experimental Medicine"},{"issue":"19","key":"10.1016\/j.molmet.2020.101008_bib24","doi-asserted-by":"crossref","first-page":"4064","DOI":"10.1182\/blood-2009-04-214916","article-title":"Dysfunctional expansion of hematopoietic stem cells and block of myeloid differentiation in lethal sepsis","volume":"114","author":"Rodriguez","year":"2009","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.molmet.2020.101008_bib25","doi-asserted-by":"crossref","first-page":"5367","DOI":"10.4049\/jimmunol.1003438","article-title":"Chronic exposure to a TLR ligand injures hematopoietic stem cells","volume":"186","author":"Esplin","year":"2011","journal-title":"The Journal of Immunology"},{"issue":"7","key":"10.1016\/j.molmet.2020.101008_bib26","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1002\/stem.1110","article-title":"Direct Toll-like receptor-mediated stimulation of hematopoietic stem and progenitor cells occurs in\u00a0vivo and promotes differentiation toward macrophages","volume":"30","author":"Megias","year":"2012","journal-title":"Stem Cells"},{"issue":"26","key":"10.1016\/j.molmet.2020.101008_bib27","doi-asserted-by":"crossref","first-page":"14843","DOI":"10.1073\/pnas.96.26.14843","article-title":"Glucose intolerance caused by a defect in the entero-insular axis: a study in gastric inhibitory polypeptide receptor knockout mice","volume":"96","author":"Miyawaki","year":"1999","journal-title":"Proceedings of the National Academy of Sciences of the U S A"},{"issue":"1","key":"10.1016\/j.molmet.2020.101008_bib28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1152\/physiolgenomics.90284.2008","article-title":"Germ line activation of the Tie2 and SMMHC promoters causes noncell-specific deletion of floxed alleles","volume":"35","author":"de Lange","year":"2008","journal-title":"Physiological Genomics"},{"issue":"3","key":"10.1016\/j.molmet.2020.101008_bib29","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.cmet.2015.02.005","article-title":"GLP-1R agonists promote normal and neoplastic intestinal growth through mechanisms requiring Fgf7","volume":"21","author":"Koehler","year":"2015","journal-title":"Cell Metabolism"},{"issue":"1","key":"10.1016\/j.molmet.2020.101008_bib30","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.cmet.2016.10.007","article-title":"Cellular sites and mechanisms linking reduction of dipeptidyl peptidase-4 activity to control of incretin hormone action and glucose homeostasis","volume":"25","author":"Mulvihill","year":"2017","journal-title":"Cell Metabolism"},{"issue":"10","key":"10.1016\/j.molmet.2020.101008_bib31","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1038\/leu.2011.127","article-title":"Notch signaling in mammalian hematopoietic stem cells","volume":"25","author":"Pajcini","year":"2011","journal-title":"Leukemia"},{"issue":"9","key":"10.1016\/j.molmet.2020.101008_bib32","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1002\/dvg.20654","article-title":"The contribution of the Tie2+ lineage to primitive and definitive hematopoietic cells","volume":"48","author":"Tang","year":"2010","journal-title":"Genesis"},{"issue":"6","key":"10.1016\/j.molmet.2020.101008_bib33","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1210\/er.2016-1078","article-title":"Vascular biology of glucagon receptor superfamily peptides: mechanistic and clinical relevance","volume":"37","author":"Pujadas","year":"2016","journal-title":"Endocrine Reviews"},{"issue":"10","key":"10.1016\/j.molmet.2020.101008_bib34","doi-asserted-by":"crossref","first-page":"3596","DOI":"10.1182\/blood.V89.10.3596","article-title":"Phenotypic and functional changes induced at the clonal level in hematopoietic stem cells after 5-fluorouracil treatment","volume":"89","author":"Randall","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.molmet.2020.101008_bib35","article-title":"Systemic TLR2 agonist exposure regulates hematopoietic stem cells via cell-autonomous and cell-non-autonomous mechanisms","volume":"6e437","author":"Herman","year":"2016","journal-title":"Blood Cancer Journal"},{"issue":"1","key":"10.1016\/j.molmet.2020.101008_bib36","doi-asserted-by":"crossref","first-page":"190","DOI":"10.2337\/db07-1202","article-title":"Differential anti-diabetic efficacy of incretin agonists vs. DPP-4 inhibition in high fat fed mice","volume":"57","author":"Lamont","year":"2008","journal-title":"Diabetes"},{"issue":"2","key":"10.1016\/j.molmet.2020.101008_bib37","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.cmet.2017.11.003","article-title":"Inactivation of the glucose-dependent insulinotropic polypeptide receptor improves outcomes following experimental myocardial infarction","volume":"27","author":"Ussher","year":"2018","journal-title":"Cell Metabolism"},{"issue":"1","key":"10.1016\/j.molmet.2020.101008_bib38","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1038\/s42255-018-0001-z","article-title":"GIP regulates inflammation and body weight by restraining myeloid-cell-derived S100A8\/A9","volume":"1","author":"Mantelmacher","year":"2019","journal-title":"Nature Metabolism"},{"issue":"5","key":"10.1016\/j.molmet.2020.101008_bib39","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1016\/j.cell.2019.07.050","article-title":"Dietary intake regulates the circulating inflammatory monocyte pool","volume":"178","author":"Jordan","year":"2019","journal-title":"Cell"},{"issue":"5","key":"10.1016\/j.molmet.2020.101008_bib40","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1016\/j.cell.2019.07.049","article-title":"The bone marrow protects and optimizes immunological memory during dietary restriction","volume":"178","author":"Collins","year":"2019","journal-title":"Cell"},{"issue":"5","key":"10.1016\/j.molmet.2020.101008_bib41","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1016\/j.cell.2019.07.047","article-title":"Fasting-refeeding impacts immune cell dynamics and mucosal immune responses","volume":"178","author":"Nagai","year":"2019","journal-title":"Cell"},{"issue":"5","key":"10.1016\/j.molmet.2020.101008_bib42","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1096\/fj.201500175","article-title":"Diet-induced obesity in mice diminishes hematopoietic stem and progenitor cells in the bone marrow","volume":"30","author":"van den Berg","year":"2016","journal-title":"The FASEB Journal"},{"issue":"1\u20132","key":"10.1016\/j.molmet.2020.101008_bib43","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.cell.2017.12.013","article-title":"Western diet triggers NLRP3-dependent innate immune reprogramming","volume":"172","author":"Christ","year":"2018","journal-title":"Cell"},{"issue":"12","key":"10.1016\/j.molmet.2020.101008_bib44","doi-asserted-by":"crossref","first-page":"4903","DOI":"10.1172\/JCI58577","article-title":"Hematopoietic AMPK beta1 reduces mouse adipose tissue macrophage inflammation and insulin resistance in obesity","volume":"121","author":"Galic","year":"2011","journal-title":"Journal of Clinical Investigation"},{"issue":"4","key":"10.1016\/j.molmet.2020.101008_bib45","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.2337\/db10-1353","article-title":"Hematopoietic cell-restricted deletion of CD36 reduces high-fat diet-induced macrophage infiltration and improves insulin signaling in adipose tissue","volume":"60","author":"Nicholls","year":"2011","journal-title":"Diabetes"},{"issue":"5","key":"10.1016\/j.molmet.2020.101008_bib46","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.cmet.2009.09.006","article-title":"Hematopoietic cell-specific deletion of toll-like receptor 4 ameliorates hepatic and adipose tissue insulin resistance in high-fat-fed mice","volume":"10","author":"Saberi","year":"2009","journal-title":"Cell Metabolism"},{"issue":"1","key":"10.1016\/j.molmet.2020.101008_bib47","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1038\/s41467-018-03145-8","article-title":"Bone marrow lympho-myeloid malfunction in obesity requires precursor cell-autonomous TLR4","volume":"9","author":"Liu","year":"2018","journal-title":"Nature Communications"},{"issue":"6","key":"10.1016\/j.molmet.2020.101008_bib48","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/j.molmet.2014.06.005","article-title":"Diet-induced obesity promotes myelopoiesis in hematopoietic stem cells","volume":"3","author":"Singer","year":"2014","journal-title":"Mol Metab"},{"issue":"6","key":"10.1016\/j.molmet.2020.101008_bib49","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1182\/blood-2018-02-832519","article-title":"Hematopoiesis and the bacterial microbiome","volume":"132","author":"Yan","year":"2018","journal-title":"Blood"},{"issue":"23","key":"10.1016\/j.molmet.2020.101008_bib50","doi-asserted-by":"crossref","first-page":"8775","DOI":"10.1074\/jbc.RA117.001526","article-title":"TLR4, TRIF, and MyD88 are essential for myelopoiesis and CD11c(+) adipose tissue macrophage production in obese mice","volume":"293","author":"Griffin","year":"2018","journal-title":"Journal of Biological Chemistry"},{"issue":"1","key":"10.1016\/j.molmet.2020.101008_bib51","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1210\/en.2014-1552","article-title":"TLR4 expression in bone marrow-derived cells is both necessary and sufficient to produce the insulin resistance phenotype in diet-induced obesity","volume":"156","author":"Razolli","year":"2015","journal-title":"Endocrinology"},{"issue":"1","key":"10.1016\/j.molmet.2020.101008_bib52","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/BF00429703","article-title":"Gastric inhibitory polypeptide (GIP) and insulin in obesity: increased response to stimulation and defective feedback control of serum levels","volume":"14","author":"Creutzfeldt","year":"1978","journal-title":"Diabetologia"},{"issue":"2","key":"10.1016\/j.molmet.2020.101008_bib53","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1210\/jcem-55-2-329","article-title":"Gastric inhibitory polypeptide release after oral glucose: relationship to glucose intolerance, diabetes mellitus, and obesity","volume":"55","author":"Salera","year":"1982","journal-title":"Journal of Clinical Endocrinology & Metabolism"},{"issue":"4","key":"10.1016\/j.molmet.2020.101008_bib54","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1007\/BF00282713","article-title":"Effect of pretreatment with a high fat diet on the gastric inhibitory polypeptide and insulin responses to oral triolein and glucose in rats","volume":"24","author":"Hampton","year":"1983","journal-title":"Diabetologia"},{"issue":"4","key":"10.1016\/j.molmet.2020.101008_bib55","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0175524","article-title":"BMT decreases HFD-induced weight gain associated with decreased preadipocyte number and insulin secretion","volume":"12","author":"Katiraei","year":"2017","journal-title":"PloS One"},{"key":"10.1016\/j.molmet.2020.101008_bib56","author":"Frias","year":"2020","journal-title":"Diabetes, Obesity and Metabolism"}],"container-title":["Molecular Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221287782030082X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221287782030082X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T13:19:15Z","timestamp":1778851155000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S221287782030082X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":56,"alternative-id":["S221287782030082X"],"URL":"https:\/\/doi.org\/10.1016\/j.molmet.2020.101008","relation":{},"ISSN":["2212-8778"],"issn-type":[{"value":"2212-8778","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The gut hormone receptor GIPR links energy availability to the control of hematopoiesis","name":"articletitle","label":"Article Title"},{"value":"Molecular Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.molmet.2020.101008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Author(s). Published by Elsevier GmbH.","name":"copyright","label":"Copyright"}],"article-number":"101008"}}